Influence of dendrimer's structure on its activity against amyloid fibril formation

被引:148
作者
Klajnert, B. [1 ]
Cortijo-Arellano, M.
Cladera, J.
Bryszewska, M.
机构
[1] Univ Lodz, Dept Gen Biophys, PL-90131 Lodz, Poland
[2] Univ Autonoma Barcelona, Dept Biochem & Mol Biol, E-08193 Barcelona, Spain
关键词
dendrimer; prion; Alzheimer; amyloid peptide; aggregation;
D O I
10.1016/j.bbrc.2006.04.041
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Inhibition of fibril assembly is a potential therapeutic strategy in neurodegenerative disorders such as prion and Alzheimer's diseases. Highly branched, globular polymers-dendrimers-are novel promising inhibitors of fibril formation. In this study, the effect of polyamidoamine (PAMAM) dendrimers (generations 3rd, 4th, and 5th) on amyloid aggregation of the prion peptide PrP 185-208 and the Alzheimer's peptide A beta 1-28 was examined. Amyloid fibrils were produced in vitro and their formation was monitored using the dye thioflavin T (ThT). Fluorescence studies were complemented with electron microscopy. The results show that the higher the dendrimer generation, the larger the degree of inhibition of the amyloid aggregation process and the more effective are dendrimers in disrupting the already existing fibrils. A hypothesis on dendrimer-peptide interaction mechanism is presented based on the dendrimers' molecular structure. (c) 2006 Elsevier Inc. All rights reserved.
引用
收藏
页码:21 / 28
页数:8
相关论文
共 31 条
[1]   Self-assembly of β-amyloid 42 is retarded by small molecular ligands at the stage of structural intermediates [J].
Bohrmann, B ;
Adrian, M ;
Dubochet, J ;
Kuner, P ;
Müller, F ;
Huber, W ;
Nordstedt, C ;
Döbeli, H .
JOURNAL OF STRUCTURAL BIOLOGY, 2000, 130 (2-3) :232-246
[2]   Water-soluble phosphorus-containing dendrimers [J].
Caminade, AM ;
Majoral, JP .
PROGRESS IN POLYMER SCIENCE, 2005, 30 (3-4) :491-505
[3]   PHOTOPHYSICAL INVESTIGATION OF STARBURST DENDRIMERS AND THEIR INTERACTIONS WITH ANIONIC AND CATIONIC SURFACTANTS [J].
CAMINATI, G ;
TURRO, NJ ;
TOMALIA, DA .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1990, 112 (23) :8515-8522
[4]   CONGO RED INHIBITION OF SCRAPIE AGENT REPLICATION [J].
CAUGHEY, B ;
ERNST, D ;
RACE, RE .
JOURNAL OF VIROLOGY, 1993, 67 (10) :6270-6272
[5]   Inhibition of protease-resistant prion protein formation by porphyrins and phthalocyanines [J].
Caughey, WS ;
Raymond, LD ;
Horiuchi, M ;
Caughey, B .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (21) :12117-12122
[6]   Glycosaminoglycans and β-amyloid, prion and tau peptides in neurodegenerative diseases [J].
Díaz-Nido, J ;
Wandosell, F ;
Avila, J .
PEPTIDES, 2002, 23 (07) :1323-1332
[7]   Poly(amidoamine) (PAMAM) dendrimers: from biomimicry to drug delivery and biomedical applications [J].
Esfand, R ;
Tomalia, DA .
DRUG DISCOVERY TODAY, 2001, 6 (08) :427-436
[8]   A beta deposition inhibitor screen using synthetic amyloid [J].
Esler, WP ;
Stimson, ER ;
Ghilardi, JR ;
Felix, AM ;
Lu, YA ;
Vinters, HV ;
Mantyh, PW ;
Maggio, JE .
NATURE BIOTECHNOLOGY, 1997, 15 (03) :258-263
[9]   A strategy for designing inhibitors of beta-amyloid toxicity [J].
Ghanta, J ;
Shen, CL ;
Kiessling, LL ;
Murphy, RM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (47) :29525-29528
[10]   Amyloid aggregates of the prion peptide PrP106-126 are destabilised by oxidation and by the action of dendrimers [J].
Heegaard, PMH ;
Pedersen, HG ;
Flink, J ;
Boas, U .
FEBS LETTERS, 2004, 577 (1-2) :127-133